Novel mRNA vaccine GLB-COV2-043 shows high efficacy against COVID-19 variants in early trials Post author: Post published:December 5, 2023 Post category:uncategorized The safety, efficacy, and immunogenicity of a mRNA-based vaccine. You Might Also Like Innovative therapy targets and destroys leukemia stem cells February 26, 2024 New perspectives on targeting BRAF alterations in cancer August 12, 2024 Discover the BIOne 250: A budget friendly bioprocess control station for microbial applications February 10, 2024
Discover the BIOne 250: A budget friendly bioprocess control station for microbial applications February 10, 2024